Special Issue "Seaweeds Secondary Metabolites: Successes In and/or Probable Therapeutic Applications 2.0"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 January 2021).
Interests: organic chemistry; medicinal chemistry; biotransformations; natural products; plant chemical profile; sustainable chemistry
Special Issues, Collections and Topics in MDPI journals
Special Issue in Marine Drugs: Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications
Topical Collection in Methods and Protocols: Green Chemistry
Special Issue in Molecules: Marine and Terrestrial Sources of Natural Products: Chemical Composition Profiling, Isolation and Characterization
Special Issue in Pharmaceuticals: Identification of Phytochemicals and Derivatives against Infectious Diseases
Special Issue in Marine Drugs: Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications 3.0
Although the use of seaweeds in gastronomy is increasing, in many countries, they are still considered unconventional food plants. Scientific evidence of their nutritional value and their health benefits is still needed and numerous researchers are dedicated to establishing the health and nutritional potential of seaweeds. Moreover, scientific research has gone further and, recently, efforts to establish the relationship between the secondary metabolites of seaweeds and health and nutritional effects have been explored.
The Special Issue "Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications” has been a success and we think that more interesting results are being achieved; therefore, a second Special Issue of Marine Drugs dedicated to this subject, seems to be essential. The Special Issue "Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications 2.0” welcomes high-quality manuscripts exploring bioactive compounds from seaweeds and their therapeutic applications.
As Guest Editor, I invite scientists to submit their latest research findings and review articles in this area and contribute interesting papers with significant advances in this field to this Special Issue of Marine Drugs.
Prof. Dr. Diana Cláudia Pinto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Secondary Metabolites
- Biological Activities
- Nutritional Supplements
- Drug delivery
- Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications in Marine Drugs (15 articles)
- Fucoidans in Marine Drugs (16 articles)
- Characterization of Bioactive Components in Edible Algae in Marine Drugs (13 articles)
- Seaweeds and Their Biological Actions in Marine Drugs (9 articles)
- Seaweeds Secondary Metabolites: Successes in and/or Probable Therapeutic Applications 3.0 in Marine Drugs (2 articles)